Short Description AI‑omics CEO hunting druggable aging pathways.
Description Kristen Fortney’s BioAge Labs harnesses longitudinal blood and biopsy omics to build machine‑learning models that predict remaining lifespan. Lead programs include a DYRK1A inhibitor (senolytic) and apelin agonist for sarcopenia; both in Phase 2. Fortney champions data transparency and women leadership in biotech.